Literature DB >> 303504

Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.

H Hashimoto, M Hayashi, Y Nakahara, T Niwaguchi, H Ishii.   

Abstract

Several D-lysergic acid diethylamide (LSD) derivatives including metabolites of LSD in animals liver and Streptomyces such as D-lysergic acid ethyl, 2-hydroxyethylamide (LEO), D-lysergic acid ethylamide (LAE), D-norlysergic acid diethylamide (norLSD) and synthetic N6-allyl-D-norlysergic acid diethylamide (allyl-nor LSD) were studied with rabbits and rats. In rabbits, the order of the hyperthermic activities was allyl-norLSD greater than LSD greater than LEO, LAE, nor-LSD, and this order was parallel to that of 5-hydroxytryptamine-like activities of these compounds which was previously studied. However, the order was LAE greater than LSD greater than norLSD IN RATS. The hyperthermic effect of LSD in rabbits was attenuated by methysergide, but not by atropine when these drugs were intraventricularly administered. These results suggest the possibility that the metabolites of LSD contribute to the hyperthermic effect of LSD in rats but not in rabbits, and support the idea that 5-HT receptors are involved in the hyperthermia induced by LSD in rabbits.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303504

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  3 in total

1.  Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2017-05-10       Impact factor: 3.345

2.  Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Tristan Colestock; Timothy E Burrow; Stephen J Chapman; Alexander Stratford; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2016-06-06       Impact factor: 3.345

3.  Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Benedikt Pulver; Hannes M Schwelm; Kyla Whitelock; Alexander Stratford; Volker Auwärter; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2022-05-29       Impact factor: 3.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.